Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
influenza vaccine, recombinant hemagglutinin (1 trial)
bpze1 (1 trial)
fedovapagon (1 trial)
vxa-g1.1-nn (1 trial)
vxa-g2.4-ns (1 trial)
flax (1 trial)
soybean (1 trial)
Caliciviridae Infections (Phase 1)
Influenza, Human (Phase 3)
Nocturia (Phase 2)
Whooping Cough (Phase 2)
Trials (5 total)
Trial APIs (7 total)